Purchase Order 75N92E20P00136

CDI Laboratories Inc., doing business as CDI Laboratories, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide 12 samples of its HUPROT V4.0 Human Proteome Microarray and HUSCAN (PHIP-SEQ) assay service. The contract calls for CDI Laboratories to deliver its proteomics platform and associated sequencing capabilities to support research efforts at the NIH aimed at better understanding...

This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to CDI Laboratories Inc. for $96,812.10. The contract is for the provision of 110 samples and bioinformatics analysis of serum samples using CDI's proprietary HuProt v4.0 protein arrays to support COVID-19 research. CDI Laboratories is a small disadvantaged business that has received numerous prime federal contracts from NIH...

The National Institute on Aging awarded a purchase order to CDI Laboratories Inc. for $20,178.74 on July 22, 2020, for Huprot Array Service. CDI Laboratories is a small disadvantaged business manufacturer based in Mayagüez, Puerto Rico. The order carries firm fixed price terms with no set-aside designation and an ultimate completion date of November 4, 2020. Place of performance is Mayagüez, Puerto Rico. The requirement addresses protein microarray analysis services, leveraging the awardee's...

This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to CD Biosciences Inc., doing business as Creative Biomart, for COVID-19 next-generation sequencing services. The $24,450.00 contract has a period of performance through September 20, 2022. CD Biosciences Inc. is a research product supplier and contract research organization that provides a wide range of specialized molecular biology services to federal agencies,...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to CDI Laboratories Inc. for immuneprofiler analysis of 30 serum samples using CDI's HuProt microarrays. The purpose is to directly compare the sample data obtained from phage immunoprecipitation sequencing (PhIP-Seq). The contract has a period of performance from April 26, 2021 to April 25, 2022 and a potential value of $218,400.00. The award...

<p>The National Institute on Aging awarded a purchase order to CDI Laboratories Inc. for serum profiling of 10 mouse serum samples, with a ceiling value of $17,561.70, on August 12, 2020. CDI Laboratories is a small disadvantaged business. Performance will take place in Mayagüez, Puerto Rico, with an ultimate completion date of September 30, 2020. The order is firm fixed price with no set-aside category.</p>

This is a $13,380 firm fixed-price purchase order awarded to CD Biosciences Inc., a small business research product supplier and contract research organization, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for TCR sequencing services, with a period of performance through August 4, 2025. CD Biosciences provides specialized scientific services, including genomic sequencing, bioinformatics analysis, and molecular biology, to support research across various...

This firm fixed-price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to CDI Laboratories Inc. of Mayagüez, Puerto Rico for $200,167.30. The contract calls for the delivery of CDI Biolabs HuProt v4.0 and VirD protein arrays within 90 days of the award date. The HuProt v4.0 array contains over 21,000 human proteins from more than 16,000 genes and has a reproducibility rate above 95%. The VirD array profiles 515 conformationally intact human...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CDI Laboratories Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract, valued at $23,999.72, is for CDI Laboratories to provide its proprietary human proteome microarray assay services to support biomedical research efforts, particularly in the areas of infectious...

This federal contract award, valued at $15,575.00, was issued by the National Heart Lung and Blood Institute (NHLBI) to CD Biosciences Inc., a small business research product supplier and contract research organization. The contract is for the provision of RNA sequencing services for 115 samples, with a completion date of May 22, 2020. The contract is a firm fixed-price purchase order, and is designated as a total small business set-aside. CD Biosciences Inc. operates under multiple divisions,...